By Abhishek Vishnoi
MUMBAI (Reuters) - The BSE Sensex slumped more than 2 percent on Monday, marking its biggest daily fall since September 3 as a rout in emerging markets hit blue chips, while lenders were hurt further by caution ahead of the Reserve Bank of India's policy review.
The Sensex has fallen 3.1 percent since hitting a record closing high on Thursday, reflecting how sentiment has changed suddenly as the U.S. Federal Reserve is poised to continue reducing its monetary stimulus and as fears rise of an economic slowdown in China.
The global factors have raised fears that foreign investors will start exiting India after buying a net $20.10 billion of shares in 2013.
Foreign institutional investors sold shares worth 1.96 billion rupees on Friday but are still net buyers of 32.77 billion rupees this year.
Investors are also cautious ahead of the RBI's policy review on Tuesday.
Although analysts still think the central bank will keep interest rates on hold, expectations of a rate hike are increasing after the central bank made fighting high consumer inflation a priority.
The NSE volatility index, considered at times as an investor fear gauge, surged 17 percent, reflecting the uncertainty.
"The market's reaction to the global contagion will be short-lived due to improvements in our current account. I think the RBI would support growth tomorrow and not just focus on inflation," said Deven Choksey, managing director at K R Choksey Securities.
The Sensex slumped 2.02 percent, or 426.11 points, to end at 20,707.45, marking its biggest daily decline since a 3.45 percent fall on September 3 when domestic shares were hit by worries about military tensions in Syria.
The broader Nifty lost 2.09 percent, or 130.90 points, to end at 6,135.85, closing below the technically important 6,200 level.
Among blue chip shares, Reliance Industries fell 2.8 percent, while Larsen and Toubro Ltd lost 2.6 percent.
Banks were among the leading decliners ahead of the RBI's policy review. ICICI Bank Ltd slumped 4.6 percent, while HDFC Bank Ltd fell 3.6 percent.
Meanwhile, Tata Motors Ltd plunged 6 percent after the automaker's managing director, Karl Slym, died when he fell from a hotel room in Bangkok in what police said on Monday could be a possible suicide.
Ranbaxy Laboratories Ltd lost 8 percent, adding to Friday's 19.43 percent plunge, as the drug maker continues to reel after the U.S. drug regulator banned more of its products.
Among stocks that gained, Glenmark Pharmaceuticals Ltd rose 5 percent after the company reported better-than-expected earnings.
Opto Circuits surged 12.5 percent after a Press Trust of India report carried by the Business Standard newspaper's website said Goldman Sachs is likely to acquire a 26 percent stake in the Indian medical equipment maker for around 3 billion rupees, citing sources.
Opto officials were not immediately reachable for comments.
(Editing by Anupama Dwivedi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
